Moreover, the MAGIC trial [23] reported that the perioperative-chemotherapy group was accompanied with significantly smaller tumor maximum diameter, a greater proportion of stage T1 and T2 tumors, and a significant trend to less advanced nodal disease (N0/1) compared to the surgery group.
← all excerpts
Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials.
1
—
—